The HDAC inhibitor LBH589 enhances the anti-myeloma effect of the IGF-1 RTK inhibitor picropodophyllin

C. Fristedt, Miguel Lemaire, P. Agarwal, Eline Menu, Els Van Valckenborgh, Peter Atadja, Benjamin Van Camp, Helena Jernberg-Wiklund, Karin Vanderkerken

Research output: Contribution to journalConference paper

Fingerprint

Dive into the research topics of 'The HDAC inhibitor LBH589 enhances the anti-myeloma effect of the IGF-1 RTK inhibitor picropodophyllin'. Together they form a unique fingerprint.

Medicine & Life Sciences